Skip to main content

Advertisement

Table 5 Diagnoses with numbers of QIs and QIs revealing non-adherence to the guidelines

From: Patient and physician related factors of adherence to evidence based guidelines in diabetes mellitus type 2, cardiovascular disease and prevention: a cross sectional study

Diagnosis n of cases with diagnosis (number of QIs) n of QIs revealing non-adherent treatment % QIs revealing non-adherent treatment (95% CI)
Arterial hypertension 424 (424) 69 16.3 (12.8-19.9)
Diabetes mellitus type 2 174 (174) 8 4.6 (1.5-7.7)
Heart failure 41 (89) 27 30.3 (20.8-39.9)
β-Blocker 41 (41) 15 36.6 (21.8-51.3)
RAAS-I 41 (41) 8 19.5 (7.4-31.6)
Aldo-A in NYHA III/IV 7 (7) 4 57.1 (20.5-93.8)
Atrial fibrillation 106 (106) 15 14.2 (7.5-20.8)
Cardiovascular disease 177 (431) 86 20.0 (16.2-23.7)
Statin 177 (177) 53 29.9 (23.2-36.7)
Platelet aggregation inhibitors 177 (177) 12 6.8 (3.1-10.5)
β-blocker after myocardial infarction 77 (77) 21 27.3 (17.3-37.2)
Total* 922 (1224) 205 16.8 (14.7-18.8)
  1. * The number of diagnoses exceeds the number of patients as many subjects had more than one of the target diagnoses.